In pregnancy, inadequate folate status not only increases neural tube defect risk but is also associated with maternal megaloblastic anemia, which can worsen fatigue, reduce exercise tolerance, and increase the likelihood of transfusion around delivery. Observational studies have linked low folate and elevated homocysteine with a higher risk of miscarriage, placental complications, and low birth weight, and some data suggest that suboptimal folate status may contribute to certain infertility contexts, particularly when combined with other nutritional or metabolic stressors. The clinical takeaway is that maintaining sufficient folate intake before conception and throughout pregnancy is a key strategy to reduce anemia and support healthier fertility and pregnancy outcomes beyond neural tube defect prevention. This medication is commonly used for Depression.
Murto, T. et al. Folic acid supplementation and IVF pregnancy outcome in women with unexplained infertility. Dey M, Dhume P, Sharma SK, Goel S, Chawla S, Shah A, Madhumidha G, Rawal R. Folic acid: The key to a healthy pregnancy - A prospective study on fetomaternal outcome. Tzu Chi Med J. 2023 Oct 31;36(1):98-102. Hariz A, Bhattacharya PT. Megaloblastic Anemia. [Updated 2023 Apr 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan. Lazar VMA, Rahman S, Chowdhury NH, Hasan T, Akter S, Islam MS, Ahmed S, Baqui AH, Khanam R. Folate deficiency in pregnancy and the risk of preterm birth: A nested case-control study. J Glob Health. 2024 Jul 12;14:04120. Zheng J-S, Guan Y, Zhao Y, et al. Pre-conceptional intake of folic acid supplements is inversely associated with risk of preterm birth and small-for-gestational-age birth: a prospective cohort study. British Journal of Nutrition. 2016;115(3):509-516. Reproductive BioMedicine Online, Volume 28, Issue 6, 766 - 772
Some side effects may be linked to nutrient depletion caused by this medication.
Research suggests that folic acid supplementation can significantly improve the effectiveness of SSRI medications such as fluoxetine (commonly known as Prozac). This benefit seems to be linked to lowering blood levels of homocysteine, an amino acid. Elevated homocysteine levels have been associated with depression. Supplementing with sufficient folic acid may help the body regulate homocysteine levels, potentially creating a more favorable environment for antidepressants to work effectively.
Research suggests the trace mineral chromium may offer some benefits for people experiencing depression, particularly those with atypical depression. Atypical depression is characterized by symptoms like increased appetite, carbohydrate cravings, and weight gain, alongside feelings of sadness and low mood. Studies show chromium supplementation might improve these specific symptoms in people with atypical depression who also have strong carbohydrate cravings. The potential explanation lies in chromium's possible effects on insulin utilization and brain chemicals like serotonin and norepinephrine, both of which are involved in mood regulation. Supplementation with chromium is suggested to support mood and help protect against depression.